
Lawrence Ho MD
Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Clinical Associate Professor Center for Interstitial Lung Disease University of Washington
Join to view full profile
1959 NE Pacific StBox 356166Seattle, WA 98195
Phone+1 206-598-4967
Dr. Ho is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Lawrence Ho, MD, is a pulmonologist based in Seattle, WA, with subspecialties in Critical Care Medicine, Interstitial Lung Diseases, and Pleural Disease. He completed his medical education at Northeast Ohio Medical University and further specialized through a fellowship at Stanford University, followed by training at the University of Washington. He holds a position as a Clinical Assistant Professor at the UW Medicine/University of Washington Medical Center. His work includes management and research in pulmonary fibrosis and interstitial lung diseases, with several published studies in prominent journals. Dr. Ho has been involved in clinical trials addressing idiopathic pulmonary fibrosis and related conditions. He has received awards including those from the American Thoracic Society and was recognized as Chief Fellow at Stanford University Medical Center.
Education & Training
University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2014
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
University of WashingtonResidency, Internal Medicine, 2008 - 2010
University of WashingtonInternship, Internal Medicine, 2007 - 2008
Northeast Ohio Medical UniversityClass of 2007
Certifications & Licensure
CA State Medical License 2010 - Present
WA State Medical License 2007 - 2027
ID State Medical License 2008 - 2025
MT State Medical License 2023 - 2025
AK State Medical License 2023 - 2024
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Abstract Scholarship Award American Thoracic Society, 2013
- Chief Fellow - Pulmonary and Critical Care Medicine Stanford University Medical Center, 2012
- Resident Development Award American Thoracic Society, 2009
Clinical Trials
Publications & Presentations
PubMed
- Fatigue, Muscular Performance, and Quadriceps Fiber Type Profile in Lymphangioleiomyomatosis and Healthy Matched Controls.Mary Beth Brown, Claire E Child, Paul Kim, Morgan L Kelly, Sophia Arons
Lung. 2026-08-16 - Remotely Monitored Home-based Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: Results of a Randomized Controlled Trial.Claire E Child, Lawrence A Ho, Emily Borders, Timothy Gray, Tor Olson
Archives of Physical Medicine and Rehabilitation. 2026-07-30 - 4 citationsUnsupervised Exercise in Interstitial Lung Disease: A Delphi Study to Develop a Consensus Preparticipation Screening Tool for Lymphangioleiomyomatosis.Claire E Child, Lawrence A Ho, Daniel Lachant, Nishant Gupta, Joel Moss
Chest. 2024-11-01
Journal Articles
- Rheumatoid Arthritis-Associated Lung DiseaseShaw M, Collins BF, Ho LA, Raghu G, Eur Resp Rev, 1/1/2015
- The diagnostic yield of navigational bronchoscopy performed with propofol deep sedationMohanasundaram U, Ho LA, Kuschner WG, Chitkara RK, Canfield J, Canfield LM, Krishna G, ISRN Endoscopy, 1/1/2013
Books/Book Chapters
Abstracts/Posters
- Effect and safety of Recombinant Human Pentraxin-2 in patients with Idiopathic Pulmonary FibrosisRaghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA Ho LA, Wisenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, G..., American Thoracic Society International Conference, San Diego, CA, 1/1/2018
- A phase 2 randomized, controlled trial of laparascopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosisRaghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters ..., American Thoracic Society International Conference, San Diego, CA, 1/1/2018
- Bronchoalveolar lavage, lung and mediastinal node biopsy have a high diagnostic yield in patients with suspected cardiac sarcoidosis regardless of chest CT findingsPetek B, Rosenthal D, Keller J, Collins BF, Patton K, Cheng R, Ho LA, Bravo P, Mikacenic C, Raghu G, American Heart Association Scientific Sessions, Anaheim, CA, 1/1/2017
Lectures
- Lung Transplantation for Patients with ILDTampa General Hospital, Tampa, FL - 1/2/2018
- Case DiscussionsDenver, CO, 2015; San Francisco, CA, 2016; Washington, DC, 2017 - 1/1/2017
- Idiopathic Pulmonary Fibrosis (IPF): New Recommendations & TherapiesProvidence and Swedish Medical Center, Lynnwood, WA - 1/14/2016
Professional Memberships
- Member
- Member
External Links
- Academic Profilehttp://www.uwmedicine.org/bios/lawrence-ho
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









